TY - JOUR
T1 - Risk Prediction Model for Cardiac Implantable Electronic Device Implantation After Transcatheter Aortic Valve Replacement
AU - Tsushima, Takahiro
AU - Nadeem, Fahd
AU - Al-Kindi, Sadeer
AU - Clevenger, Joshua R.
AU - Bansal, Eric J.
AU - Wheat, Heather L.
AU - Kalra, Ankur
AU - Attizzani, Guilherme F.
AU - Elgudin, Yakov
AU - Markowitz, Alan
AU - Costa, Marco A.
AU - Simon, Daniel I.
AU - Arruda, Mauricio S.
AU - Mackall, Judith A.
AU - Thal, Sergio G.
N1 - Publisher Copyright:
© 2020 American College of Cardiology Foundation
PY - 2020/3
Y1 - 2020/3
N2 - Objectives: The aim of this study was to develop and validate a risk prediction model for high-grade atrioventricular block requiring cardiac implantable electronic device (CIED) implantation after transcatheter aortic valve replacement (TAVR). Background: High-grade atrioventricular block requiring CIED remains a significant sequelae following TAVR. Although several pre-operative characteristics have been associated with the risk of post-operative CIED implantation, an accurate and validated risk prediction model is not established yet. Methods: This was a single center, retrospective study of consecutive patients who underwent TAVR from March 10, 2011, to October 8, 2018. This cohort sample was randomly divided into a derivation cohort (group A) and a validation cohort (group B). A scoring system for risk prediction of post-TAVR CIED implantation was devised using logistic regression estimates in group A and the calibration and validation were done in group B. Results: A total of 1,071 patients underwent TAVR during the study period. After excluding pre-existing CIED, a total of 888 cases were analyzed (group A: 507 and group B: 381). Independent predictive variables were as follows: self-expanding valve (1 point), hypertension (1 point), pre-existing first-degree atrioventricular block (1 point), and right bundle branch block (2 points). The resulting score was calculated from the total points. The internal validation in group B showed an ideal linear relationship in calibration plot (R2 = 0.933) and a good predictive accuracy (area under the curve: 0.693; 95% confidence interval: 0.627 to 0.759). Conclusions: This prediction model accurately predicts post-operative risk of CIED implantation with simple pre-operative parameters.
AB - Objectives: The aim of this study was to develop and validate a risk prediction model for high-grade atrioventricular block requiring cardiac implantable electronic device (CIED) implantation after transcatheter aortic valve replacement (TAVR). Background: High-grade atrioventricular block requiring CIED remains a significant sequelae following TAVR. Although several pre-operative characteristics have been associated with the risk of post-operative CIED implantation, an accurate and validated risk prediction model is not established yet. Methods: This was a single center, retrospective study of consecutive patients who underwent TAVR from March 10, 2011, to October 8, 2018. This cohort sample was randomly divided into a derivation cohort (group A) and a validation cohort (group B). A scoring system for risk prediction of post-TAVR CIED implantation was devised using logistic regression estimates in group A and the calibration and validation were done in group B. Results: A total of 1,071 patients underwent TAVR during the study period. After excluding pre-existing CIED, a total of 888 cases were analyzed (group A: 507 and group B: 381). Independent predictive variables were as follows: self-expanding valve (1 point), hypertension (1 point), pre-existing first-degree atrioventricular block (1 point), and right bundle branch block (2 points). The resulting score was calculated from the total points. The internal validation in group B showed an ideal linear relationship in calibration plot (R2 = 0.933) and a good predictive accuracy (area under the curve: 0.693; 95% confidence interval: 0.627 to 0.759). Conclusions: This prediction model accurately predicts post-operative risk of CIED implantation with simple pre-operative parameters.
KW - atrioventricular block
KW - cardiac implantable electronic device
KW - risk prediction
KW - transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85081020124&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081020124&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2019.10.020
DO - 10.1016/j.jacep.2019.10.020
M3 - Article
C2 - 32192680
AN - SCOPUS:85081020124
SN - 2405-500X
VL - 6
SP - 295
EP - 303
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 3
ER -